NGF protects Dorsal Root Ganglion neurons from oxaliplatin by modulating JNK/Sapk and ERK1/2

Neuroscience Letters

Volumn 486, Issue 3, 2010, Pages 141-145

  Scuteri, Arianna ^a   Galimberti, Alessia ^a   Ravasi, Maddalena ^a   Pasini, Silvia ^a   Donzelli, Elisabetta ^a   Cavaletti, Guido ^a   Tredici, Giovanni ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Dorsal Root Ganglion neurons; MAPKs; Neuronal differentiation; Neuronal toxicity; NGF; Oxaliplatin

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ANTINEOPLASTIC AGENT; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; NERVE GROWTH FACTOR; OXALIPLATIN; PLATINUM DERIVATIVE; RETINOIC ACID; UO 126;

ANIMAL CELL; ARTICLE; CANCER CHEMOTHERAPY; CELL CYCLE; CONTROLLED STUDY; DRUG EFFECT; EMBRYO; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; NERVE CELL DIFFERENTIATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAT; SPINAL GANGLION;

ANIMALS; ANTINEOPLASTIC AGENTS; CELLS, CULTURED; GANGLIA, SPINAL; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE 8; NERVE GROWTH FACTOR; NEUROPROTECTIVE AGENTS; ORGANOPLATINUM COMPOUNDS; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 78049389903     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.09.028     Document Type: Article

References (27)

1. (+) channel kinetics on rat sensory neurons. Eur. J. Pharmacol. 2000, 1:25-32.
2. Ahn N.G., Nahreini T.S., Tolwinski N.S., Resing K.A. Pharmacologic inhibitors of MKK1 and MKK2. Meth. Enzymol. 2001, 332:417-431.
3. Apfel S.C., Arezzo J.C., Lipson L., Kessler J.A. Nerve growth factor prevents experimental cisplatin neuropathy. Ann. Neurol. 1992, 31:76-80.
4. Apfel S.C. Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold?. Int. Rev. Neurobiol. 2002, 50:393-413.
5. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Satoh Y., Bhagwat S.S., Manning A.M., Anderson D.W. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. U.S.A. 2001, 20:13681-13686.
6. Cavaletti G., Miloso M., Nicolini G., Scuteri A., Tredici G. Emerging role of mitogen-activated protein kinases in peripheral neuropathies. J. Peripher. Nerv. Syst. 2007, 12:175-194.
7. Cavaletti G., Petruccioli M.G., Marmiroli P., Rigolio R., Galbiati S., Zoia C., Ferrarese C., Tagliabue E., Dolci C., Bayssas M., Griffon Etienne G., Tredici G. Circulating nerve growth factor level changes during oxaliplatin treatment-induced neurotoxicity in the rat. Anticancer Res. 2002, 22:4199-4204.
8. Cavaletti G., Pezzoni G., Pisano C., Oggioni N., Sala F., Zoia C., Ferrarese C., Marmiroli P., Tredici G. Cisplatin-induced peripheral neurotoxicity in rats reduces the circulating levels of nerve growth factor. Neurosci. Lett. 2002, 322:103-106.
9. Cavaletti G., Tredici G., Petruccioli M.G., Dondè E., Tredici P., Marmiroli P., Minoia C., Ronchi A., Bayssas M., Griffon Etienne G. Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat. Eur. J. Cancer 2001, 37:257-263.
10. Copani A., Uberti D., Sortino M.A., Bruno V., Nicoletti F., Memo M. Activation of cell-cycle associated proteins in neuronal death: a mandatory or dispensable path?. Trends Neurosci. 2001, 24:25-31.
11. Donzelli E., Carfì M., Miloso M., Strada A., Galbiati S., Tredici G. Neurotoxicity of platinum compounds: comparison of effects of cisplatin and oxaliplatin on the human neuroblastoma cell line SH-SY5Y. J. Neurooncol. 2004, 67:65-73.
12. Fisher S., McDonald E., Gross L., Windebank A.J. Alterations in cell cycle regulation underlie cisplatin induced apoptosis of dorsal root ganglion neurons in vivo. Neurobiol. Dis. 2001, 8:1027-1035.
13. Fisher S., Podratz J.L., Windebank A.J. Nerve growth factor rescue of cisplatin neurotoxicity is mediated through the high affinity receptor: studies in PC12 cells and p75 null mouse dorsal root ganglia. Neurosci. Lett. 2001, 308:1-4.
14. Gill J.S., Windebank A.J. Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle. J. Clin. Invest. 1998, 101:2842-2851.
15. Glotin A.L., Calipel A., Brossas J.Y., Faussat A.M., Tréton J., Mascarelli F. Sustained versus transient ERK1/2 signaling underlies the anti- and proapoptotic effects of oxidative stress in human RPE cells. Invest. Ophthalmol. Vis. Sci. 2006, 47:4614-4623.
16. Grolleau F., Gamelin L., Boisdron-Celle M., Lapide B., Pelhate M., Gamelin E. A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels. J. Neurophysiol. 2001, 85:2293-2297.
17. Isaacson L.G., Saffran B.N., Crutcher K.A. Intracerebral NGF infusion induces hyperinnervation of cerebral blood vessels. Neurobiol. Aging 1990, 11:51-55.
18. Lee X., Yang Z., Shao Z., Rosenberg S.S., Levesque M., Pepinsky R.B., Qiu M., Miller R.H., Chan J.R., Mi S. NGF regulates the expression of axonal LINGO-1 to inhibit oligodendrocyte differentiation and myelination. J. Neurosci. 2007, 27:220-225.
19. Lewin G.R., Ritter A.M., Mendell L.M. Nerve growth factor-induced hyperalgesia in the neonatal and adult rat. J. Neurosci. 1993, 13:1903-1912.
20. Lewis T.S., Shapiro P.S., Ahn N.G. Signal transduction through MAP kinase cascades. Adv. Cancer Res. 1998, 74:49-139.
21. Misset J.L. Oxaliplatin in practice. Br. J. Cancer 1998, 77:4-7.
22. McDonald E.S., Randon K.R., Knight A., Windebank A.J. Cisplatin preferentially binds to DNA in dorsal root ganglion neurons in vitro and in vivo: a potential mechanism for neurotoxicity. Neurobiol. Dis. 2005, 18:305-313.
23. Raymond E., Chaney S.G., Taamma A., Cvitkovic E. Oxaliplatin: a review of preclinical and clinical studies. Ann. Oncol. 1998, 9:1053-1071.
24. Scuteri A., Cassetti A., Tredici G. Adult mesenchymal stem cells rescue dorsal root ganglia neurons from dying. Brain Res. 2006, 1116:75-81.
25. Scuteri A., Galimberti A., Maggioni D., Ravasi M., Pasini S., Nicolini G., Bossi M., Miloso M., Cavaletti G., Tredici G. Role of MAPKs in platinum-induced neuronal apoptosis. Neurotoxicology 2009, 30:312-319.
26. Tredici G., Tredici S., Fabbrica D., Minoia C., Cavaletti G. Experimental cisplatin neuronopathy in rats and the effect of retinoic acid administration. J. Neurooncol. 1998, 36:31-40.
27. William L.R., Varon S., Peterson G.M., Wictorin K., Fisher W., Bjorklund A., Gage F.H. Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transaction. Proc. Natl. Acad. Sci. U.S.A. 1986, 83:9231-9235.